Use of Intravenous Gamma Globulin and Corticosteroids in the Treatment of Maternal Autoantibody-Mediated Cardiomyopathy
Authors:
- Edgar JaeggiEJEdgar Jaeggi
- Bettina CuneoBCBettina Cuneo
- Anita J. Moon-GradyAMAnita J. Moon-Grady
- Earl SilvermanESEarl Silverman
- Norman SilvermanNSNorman Silverman
- Lisa K. HornbergerLHLisa K. Hornberger
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Determinants of early dilated cardiomyopathy in neonates with congenital complete atrioventricular blockEP Europace, 2010
- An expanded phenotype of maternal SSA/SSB antibody-associated fetal cardiac diseaseThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiographyHeart, 2006
- IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patientsAutoimmunity, 2005
- Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stressInternational Journal of Cardiology, 2003
- Cardiac dimensions determined by cross-sectional echocardiography in the normal human fetus from 18 weeks to termThe American Journal of Cardiology, 1992
- Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodiesThe American Journal of Cardiology, 1986
- Maternal Connective Tissue Disease and Congenital Heart BlockNew England Journal of Medicine, 1985
- Fetal echocardiographyThe American Journal of Cardiology, 1983
- Lack of connection between the atria and the more peripheral conduction system in congenital atrioventricular blockThe American Journal of Cardiology, 1971